See also this year's filing and all EDGAR filings for this company.
PDF Report 0000744218_2021_Celldex_Therapeutics_Inc.pdf
Logs
| info | NetIncome node detected by tax heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest'} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000744218, Celldex Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | LiabilitiesNoncurrent | 12,275,000 |
| 1 | LiabilitiesCurrent | 14,206,000 |
| 2 | remainder_Liabilities | 0 |
| 3 | AssetsCurrent | 197,843,000 |
| 4 | AssetsNoncurrent | 3,490,000 |
| 5 | PropertyPlantAndEquipmentNet | 3,815,000 |
| 6 | Goodwill | 30,690,000 |
| 7 | remainder_Assets | 0 |
| 8 | GeneralAndAdministrativeExpense | 14,456,000 |
| 9 | ResearchAndDevelopmentExpense | 42,534,000 |
| 10 | remainder_Expenses | 12,615,000 |
| 11 | remainder_Revenues | 9,825,000 |
| 12 | remainder_NetIncome | -30,000 |
| 13 | remainder_ComprehensiveNetIncome | -59,810,000 |
| yvar | yval | |
|---|---|---|
| 0 | Liabilities | 26,481,000 |
| 1 | Assets | 235,838,000 |
| 2 | Expenses | 69,605,000 |
| 3 | Revenues | 9,825,000 |
| 4 | StockholdersEquity | 209,357,000 |
| 5 | NetIncome | -59,810,000 |
| 6 | ComprehensiveNetIncome | -89,715,000 |
| 7 | BaseVar | 200,794,500 |
| 8 | EconomicCapitalRatio | 0.673 |
Edgar->Model Mapping
Feature Distribution
Change over Time
